PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsBacitracin
Bacitracin
Bacitracin, Bacitracin / / Neomycin / Polymyxin B, Bacitracin / Neomycin / Polymyxin B, Bacitracin / Polymyxin B, Lumi-sporyn, Mycitracin (bacitracin) is a protein pharmaceutical. Bacitracin was first approved as Bacitracin on 1982-01-01. It is used to treat bacterial eye infections, bacterial skin diseases, empyema, pneumonia, and pseudomembranous enterocolitis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
respiratory tract diseasesD012140
eye diseasesD005128
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Bacitracin (discontinued: Baciguent, Bacitracin)
Combinations
Bacitracin polymyxin b, Bacitracin-neomycin-polymyxin w/ hydrocortisone, Lumi-sporyn, Neomycin polymyxin b sulfates bacitracin, Neomycin polymyxin b sulfates, bacitracin hydrocortisone (discontinued: Bacitracin polymyxin b, Bacitracin-neomycin-polymyxin, Bacitracin-neomycin-polymyxin w/ hydrocortisone, Cortisporin, Lanabiotic, Mycitracin, Neo-polycin, Neomycin polymyxin b sulfates bacitracin, Neomycin polymyxin b sulfates, bacitracin hydrocortisone, Polysporin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bacitracin zinc
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
POLYSPORINGSKN-050167 DISCN1985-03-01
1 products
Hide discontinued
Bacitracin zinc
+
Hydrocortisone
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
CORTISPORINCasper PharmaN-050416 DISCN1982-01-01
1 products, RLD
CORTISPORINMonarch PharmaceuticalsN-050168 DISCN1984-05-04
1 products, RLD
Hide discontinued
Bacitracin
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
LANABIOTICCombeN-050598 DISCN1986-09-22
1 products
Hide discontinued
Bacitracin zinc
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
LUMI-SPORYNCasper PharmaN-050417 RX1982-01-01
1 products, RLD
Labels
FDA
EMA
Brand Name
Status
Last Update
0.9g triple antibioticOTC monograph final2022-03-24
10 person ansiOTC monograph final2010-06-07
25 person ansiOTC monograph final2010-06-07
4314 first aid kit 4315 first aid kitunapproved drug other2019-05-10
50 person ansiOTC monograph final2010-06-07
acme first aid contains 404 piecesOTC monograph final2010-06-07
acme small cuts and burnsOTC monograph final2010-06-14
advanced first aid bacitracinOTC monograph final2016-10-18
adventure first aid .5 tinOTC monograph not final2017-03-16
adventure medical kits 1-2 person first aidOTC monograph not final2011-01-11
Show 339 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
pneumoniaEFO_0003106D011014—
bacterial skin diseases—D017192—
streptococcal infectionsEFO_1001476D013290—
bacterial eye infections—D015818—
staphylococcal infections—D013203A49.01
empyemaEFO_0003097D004653—
pseudomembranous enterocolitisEFO_1001314D004761A04.7
wounds and injuries—D014947T14.8
gastrointestinal diseases—D005767—
bacterial infections—D001424A49
Show 35 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06A: Antibiotics for topical use
— D06AX: Other antibiotics for topical use in atc
— D06AX05: Bacitracin
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01X: Other antibacterials in atc
— J01XX: Other antibacterials in atc
— J01XX10: Bacitracin
R: Respiratory system drugs
— R02: Throat preparations
— R02A: Throat preparations
— R02AB: Antibiotic throat preparations
— R02AB04: Bacitracin
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameBacitracin
INNbacitracin
Description
Bacitracin is a mixture of related cyclic peptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy, first isolated in 1945. These peptides disrupt Gram-positive bacteria by interfering with cell wall and peptidoglycan synthesis.
Classification
Protein
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1
Identifiers
PDB—
CAS-ID22601-59-8
RxCUI—
ChEMBL IDCHEMBL1200558
ChEBI ID35862
PubChem CID439542
DrugBankDB00626
UNII ID58H6RWO52I (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Bacitracin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Bacitracin
+
Neomycin
+
Polymyxin b
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Bacitracin
+
Polymyxin b
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Bacitracin
+
Polymyxin b
+
Pramoxine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use